Transactions

AcelRx Pharmaceuticals, Inc.’s strategic review, including co-promotion agreement and acquisition of Tetraphase Pharmaceuticals, Inc.

Date Announced:
03/15/2020

client:
AcelRx Pharmaceuticals, Inc.

Status:
Withdrawn

Value:
Undisclosed